NFE2L2 and familial pancreatic carcinoma: The research also demonstrated that plasma-treated, water-derived oxidants sensitize pancreatic cancer cells to ferroptotic cell death by targeting a NRF2–HMOX1–GPX4 specific kinase signaling network [120].